Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The primary objective of this study is to evaluate the pharmacokinetics, safety, and tolerability of voxilaprevir (formerly GS-9857) in participants with severe renal impairment and matched healthy control participants.
Epistemonikos ID: 4dcce14f6dea2f9139e79b28eedac6d9ca3a6e5d
First added on: May 12, 2024